Hydroxychloroquin (HCQ) in chILD of Genetic Defect
Status:
Recruiting
Trial end date:
2026-07-30
Target enrollment:
Participant gender:
Summary
The purpose of this proposed research is to investigate the efficacy and safety of
hydroxychloroquine sulfate (HCQ, Quensyl) for pediatric ILD(chILD) caused by pulmonary
surfactant-associated genes mutations.